The University of Botswana’s Department of Chemistry announced on June 20, 2026, that a research team led by Dr. Naledi Molefe achieved a breakthrough in cross-coupling reactions, demonstrating that stereochemistry of chiral carboxylic acids remains preserved under specific catalytic conditions. The findings, published in Nature Chemistry, were confirmed through nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry.
Scientific Breakthrough in Stereochemistry
The study, titled “Stereochemical Integrity in Cross-Coupling of Chiral Carboxylic Acids,” addresses a longstanding challenge in organic synthesis: maintaining the three-dimensional structure of chiral molecules during chemical reactions. Dr. Molefe’s team used palladium-based catalysts with modified ligands to achieve selective coupling, avoiding racemization. “Our results show that the stereochemistry of the carboxylic acid’s chiral center is retained with over 95% fidelity,” Molefe stated in a press release.
The research focused on α-chloroacetic acid derivatives, a common class of chiral molecules. By optimizing reaction temperatures and solvent polarity, the team reduced side reactions that typically disrupt stereochemical configurations. The findings were independently verified by the South African National Research Foundation’s chemical analysis unit, which confirmed the data using high-resolution mass spectrometry.
Methodology and Findings
The experiments involved three phases: synthesis of chiral precursors, cross-coupling reactions under varied conditions, and post-reaction analysis. The team tested 12 catalyst systems, with the most effective demonstrating a 92% yield of the desired stereoisomer. “The key innovation was the ligand’s steric bulk, which minimized undesired pathways,” explained Dr. Thabo Sekoto, a co-author and organic chemist at the University of Botswana.
NMR spectroscopy revealed no evidence of epimerization, a process where the chiral center flips its configuration. The team also observed a 78% reduction in byproduct formation compared to traditional methods. These results were corroborated by a parallel study conducted at the University of Cape Town, which used computational modeling to simulate the reaction mechanisms.
Implications for Pharmaceutical Research
The discovery holds significant potential for pharmaceutical development, where stereochemistry directly impacts drug efficacy and safety. Many drugs, such as ibuprofen and thalidomide, exhibit different biological activities depending on their chiral forms. “This method could streamline the production of enantiopure compounds, reducing costs and improving reliability,” noted Dr. Linda Ngcobo, a medicinal chemist at the Council for Scientific and Industrial Research (CSIR) in South Africa.
The study’s authors highlighted applications in synthesizing anti-cancer agents and antibiotics. For example, the team demonstrated the method’s compatibility with complex molecules like penicillin derivatives, which require precise stereochemical control. A spokesperson for Merck South Africa, which funded part of the research, stated the findings “could accelerate the development of next-generation therapies.”
Expert Reactions and Future Directions
The scientific community has responded with cautious optimism. Dr. Amina Salim, a synthetic chemist at the University of Nairobi, called the work “a critical step forward” but emphasized the need for larger-scale trials. “While the lab results are promising, industrial adoption depends on scalability and cost-effectiveness,” she said.
The University of Botswana plans to collaborate with industry partners to test the method in pilot production facilities. The research team also aims to extend the technique to other classes of chiral molecules, including amines and alcohols. A follow-up study, pending approval from the Botswana Research Ethics Board, will investigate the environmental impact of the catalysts used.
Why It Matters
This breakthrough aligns with global efforts to enhance green chemistry practices. By minimizing byproducts and improving reaction efficiency, the method reduces waste and energy consumption. It also addresses a gap in current cross-coupling techniques, which often struggle with chiral substrates.
The findings underscore the growing role of African institutions in advancing chemical sciences. Dr. Molefe’s team, comprising researchers from Botswana, Kenya, and South Africa, reflects a regional collaboration increasingly recognized in international journals. As the pharmaceutical industry seeks more sustainable processes, this work provides a tangible example of how localized innovation can contribute to global challenges.
The next phase of research will focus on commercial viability, with potential partnerships announced by late 2026. For now, the study stands as a testament to the precision achievable in modern synthetic chemistry.
Find more reporting in our News section.
